Grifols (GIKLY) Total Liabilities (2010 - 2025)

Grifols (GIKLY) reported Total Liabilities of $14.1 billion for Q4 2025, up 3.06% on a YoY basis from $13.7 billion in Q4 2024, and up 3.06% quarter-over-quarter from $13.7 billion in Q4 2024.

Grifols (GIKLY) Total Liabilities (2010 - 2025) Analysis & Trends

Grifols has reported Total Liabilities for 16 years, with the latest figure at $14.1 billion in Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 3.06% year-over-year to $14.1 billion; the trailing twelve-month figure through Dec 2025 stood at $14.1 billion (up 3.06% YoY), and the FY2025 full-year result was $14.1 billion, up 13584.86% from the prior year.
  • Total Liabilities for Q4 2025 stood at $14.1 billion, up from $13.7 billion in the prior quarter.
  • The five-year high for Total Liabilities was $14.5 billion in Q4 2023, with the low at $13.5 billion in Q4 2022.
  • Historically, Total Liabilities has averaged $13.9 billion across 5 years, with a median of $13.7 billion in 2024.
  • Annual changes were most pronounced in 2021 — Total Liabilities soared 33.65% — and 2024, when it retreated 5.69%.
  • Grifols' Total Liabilities stood at $13.6 billion in 2021, then decreased by 0.81% to $13.5 billion in 2022, then gained by 7.25% to $14.5 billion in 2023, then declined by 5.69% to $13.7 billion in 2024, then rose by 3.06% to $14.1 billion in 2025.
  • The last three Total Liabilities figures came in at $14.1 billion (Q4 2025), $13.7 billion (Q4 2024), and $14.5 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -61.27 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 85.38 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 119.71 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 143.08 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 82.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 83.31 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 32.76 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 117.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 66.37 Bn
10 Grifols - - - 14.10 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.10 Bn
Dec 31, 2024 13.68 Bn
Dec 31, 2023 14.50 Bn
Dec 31, 2022 13.52 Bn
Dec 31, 2021 13.63 Bn
Dec 31, 2020 10.20 Bn
Sep 30, 2020 9.97 Bn
Mar 31, 2020 9.59 Bn
Dec 31, 2019 9.63 Bn
Sep 30, 2019 9.73 Bn
Dec 31, 2018 8.88 Bn
Sep 30, 2018 8.88 Bn
Jun 30, 2018 8.91 Bn
Mar 31, 2018 10.45 Bn
Dec 31, 2017 8.58 Bn
Jun 30, 2017 8.28 Bn
Dec 31, 2016 6.91 Bn
Sep 30, 2016 6.74 Bn
Jun 30, 2016 6.92 Bn
Mar 31, 2016 100.59 Mn